HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could two HPV shots be enough for older women? new study aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether two doses of the HPV vaccine work as well as three doses for women aged 27 to 45. About 618 women will be randomly assigned to receive either two or three shots, and their immune response will be checked over 12 months. The goal is to see if a shorter vac…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:04 UTC
-
New HPV test aims to make screening easier and more accessible
Diagnosis Recruiting nowThis study is testing a new point-of-care HPV test that requires less equipment than current tests, potentially making screening more accessible. Researchers will enroll 600 people with a cervix aged 21 and older to compare the new test's accuracy with standard HPV tests. The goa…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 06, 2026 16:01 UTC
-
Scientists hunt for genetic clues behind tough HPV cases
Knowledge-focused Recruiting nowThis study aims to understand why some people develop severe, hard-to-treat HPV infections while others don't. Researchers will collect medical history, blood, and tissue samples from 850 participants aged 3 and older, including healthy relatives. The goal is to find genetic and …
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC